Genomic profiles of Indonesian colorectal cancer patients.
F1000Research
Abdullah, Murdani M; Meilany, Sofy S; Trimarsanto, Hidayat H; Malik, Safarina G SG; Sukartini, Ninik N; Idrus, Firhat F; Nursyirwan, Saskia A SA; Muzellina, Virly N VN; Pribadi, Rabbinu R RR; Utari, Amanda P AP; Maulahela, Hasan H; Syam, Ari F AF
Next-generation whole exome sequencing to delineate the genetic basis of primary congenital glaucoma.
Scientific Reports
Rauf, Bushra B; Khan, Shahid Y SY; Jiao, Xiaodong X; Irum, Bushra B; Ashfaq, Ramla R; Zehra, Mubashra M; Khan, Asma A AA; Naeem, Muhammad Asif MA; Shahzad, Mohsin M; Riazuddin, Sheikh S; Hejtmancik, J Fielding JF; Riazuddin, S Amer SA
Selection of Effective Therapies Using Three-Dimensional in vitro Modeling of Chondrosarcoma.
Frontiers In Molecular Biosciences
Palubeckaitė, Ieva I; Venneker, Sanne S; Briaire-de Bruijn, Inge H IH; van den Akker, Brendy E BE; Krol, Augustinus D AD; Gelderblom, Hans H; Bovée, Judith V M G JVMG
Adamantinomatous Craniopharyngioma in an Adult: A Case Report with NGS Analysis.
International Medical Case Reports Journal
Jastania, Raid A RA; Saeed, Muhammad M; Al-Khalidi, Hisham H; AlQuthami, Khalid K; Nageeti, Tahani H TH; Al-Allaf, Faisal A FA; Valerie, Kristoffer K; Taher, Mohiuddin M MM
Detection Of Mutations In The Isocitrate Dehydrogenase Genes (IDH1/IDH2) Using castPCRTM In Patients With AML And Their Clinical Impact In Mexico City.
Oncotargets And Therapy
Olarte, Irma I; García, Anel A; Ramos, Christian C; Arratia, Brenda B; Centeno, Federico F; Paredes, Johanna J; Rozen, Etta E; Kassack, Juan J; Collazo, Juan J; Martínez, Adolfo A
Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT.
Acta Neuropathologica Communications
Jungwirth, Gerhard G; Warta, Rolf R; Beynon, Christopher C; Sahm, Felix F; von Deimling, Andreas A; Unterberg, Andreas A; Herold-Mende, Christel C; Jungk, Christine C
Genetic and transcriptional evolution alters cancer cell line drug response.
Nature
Ben-David, Uri U; Siranosian, Benjamin B; Ha, Gavin G; Tang, Helen H; Oren, Yaara Y; Hinohara, Kunihiko K; Strathdee, Craig A CA; Dempster, Joshua J; Lyons, Nicholas J NJ; Burns, Robert R; Nag, Anwesha A; Kugener, Guillaume G; Cimini, Beth B; Tsvetkov, Peter P; Maruvka, Yosef E YE; O'Rourke, Ryan R; Garrity, Anthony A; Tubelli, Andrew A AA; Bandopadhayay, Pratiti P; Tsherniak, Aviad A; Vazquez, Francisca F; Wong, Bang B; Birger, Chet C; Ghandi, Mahmoud M; Thorner, Aaron R AR; Bittker, Joshua A JA; Meyerson, Matthew M; Getz, Gad G; Beroukhim, Rameen R; Golub, Todd R TR
IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas.
Clinical Sarcoma Research
Cleven, Arjen H G AHG; Suijker, Johnny J; Agrogiannis, Georgios G; Briaire-de Bruijn, Inge H IH; Frizzell, Norma N; Hoekstra, Attje S AS; Wijers-Koster, Pauline M PM; Cleton-Jansen, Anne-Marie AM; Bovée, Judith V M G JVMG
Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SNP 105C > T have a prognostic value in acute myeloid leukemia.
Biomarker Research
Willander, Kerstin K; Falk, Ingrid Jakobsen IJ; Chaireti, Roza R; Paul, Esbjörn E; Hermansson, Monica M; Gréen, Henrik H; Lotfi, Kourosh K; Söderkvist, Peter P
Loss of TRIM62 expression is an independent adverse prognostic factor in acute myeloid leukemia.
Clinical Lymphoma, Myeloma & Leukemia
Quintás-Cardama, Alfonso A; Zhang, Nianxiang N; Qiu, Yi Hua YH; Post, Sean S; Creighton, Chad J CJ; Cortes, Jorge J; Coombes, Kevin R KR; Kornblau, Steven M SM
IDH1/IDH2 but not TP53 mutations predict prognosis in Bulgarian glioblastoma patients.
Biomed Research International
Stancheva, Gergana G; Goranova, Teodora T; Laleva, Maria M; Kamenova, Margarita M; Mitkova, Atanaska A; Velinov, Nikolay N; Poptodorov, George G; Mitev, Vanio V; Kaneva, Radka R; Gabrovsky, Nikolay N
Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.
Journal Of Hematology & Oncology
Chotirat, Sadudee S; Thongnoppakhun, Wanna W; Promsuwicha, Orathai O; Boonthimat, Chetsada C; Auewarakul, Chirayu U CU
Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.
Leukemia
Ho, P A PA; Alonzo, T A TA; Kopecky, K J KJ; Miller, K L KL; Kuhn, J J; Zeng, R R; Gerbing, R B RB; Raimondi, S C SC; Hirsch, B A BA; Oehler, V V; Hurwitz, C A CA; Franklin, J L JL; Gamis, A S AS; Petersdorf, S H SH; Anderson, J E JE; Reaman, G H GH; Baker, L H LH; Willman, C L CL; Bernstein, I D ID; Radich, J P JP; Appelbaum, F R FR; Stirewalt, D L DL; Meshinchi, S S
Mutations of the metabolic genes IDH1, IDH2, and SDHAF2 are not major determinants of the pseudohypoxic phenotype of sporadic pheochromocytomas and paragangliomas.
The Journal Of Clinical Endocrinology And Metabolism
Yao, Li L; Barontini, Marta M; Niederle, Bruno B; Jech, Marion M; Pfragner, Roswitha R; Dahia, Patricia L M PL